IVVD Stock Analysis: Buy, Sell, or Hold?
IVVD - Invivyd, Inc. Common Stock
$1.88
0.14 (8.05%)
▲
5d:
-7.39%
30d:
-24.8%
90d:
+6.82%
HOLD
LOW Confidence
Last Updated: February 3, 2026
Earnings: Mar 19, 2026
Get Alerted When IVVD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called IVVD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IVVD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IVVD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IVVD is currently trading at $1.88, which is considered oversold relative to its 30-day fair value range of $2.00 to $2.56.
Technical Outlook: Technically, IVVD is in a strong uptrend. Immediate support is located at $1.72, while resistance sits at $2.31. The stock is showing strong short-term momentum, up 8.0% recently.
Market Sentiment: IVVD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.00 (+431.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IVVD is in a strong uptrend. Immediate support is located at $1.72, while resistance sits at $2.31. The stock is showing strong short-term momentum, up 8.0% recently.
Market Sentiment: IVVD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.00 (+431.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.00 -
$2.56
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.0%)
- BULLISH: Trading 431.9% below Wall St target ($10.00)
- CAUTION: Recommendation downgraded due to -7.4% 5-day decline
Fair Price Analysis
30-Day Fair Range
$2.00 -
$2.56
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.72
Resistance Level
$2.31
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-13.93
Wall Street Target
$10.00
(+431.9%)
Revenue Growth (YoY)
41.2%
Profit Margin
-119.6%
Last updated: February 03, 2026 6:42 PM ET
Data refreshes hourly during market hours. Next update: 7:42 PM
Data refreshes hourly during market hours. Next update: 7:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVVD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Julie Green
SELL
29643 shares
2025-08-19
Robert D Allen III
SELL
27420 shares
2025-08-19
Timothy Edward Lee
SELL
29643 shares
2025-08-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 51 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 61 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 61 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$847 | 53 HOLD |
